2026-07-02 The Authority mRNA Technology Shapes the Future of Modern Therapies: SFDA Advances Regulatory Frameworks to Foster Innovation and Protect Patient Safety
2026-06-29 Drugs SFDA Approves Registration of “Iqirvo” for the Treatment of Primary Biliary Cholangitis
2026-06-22 The Authority SFDA Grants Marketing Authorization for AI-Powered Medical App to Measure Vital Signs
2026-06-07 Drugs SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
2026-06-04 Drugs The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Multiple Myeloma
2026-05-24 The Authority, Drugs SFDA Grants Breakthrough Designation to Prevent and Reduce Bleeding Episodes in Patients with Hemophilia A
2026-05-15 Drugs SFDA Approves Registration of New Treatment for Advanced or Metastatic Breast Cancer with a Gene Mutation
2026-03-10 Drugs SFDA Grants Breakthrough Designation to "Bemlayo" for Adults with Obesity or Overweight
